November 2024, On the Horizon -
U.S. equity returns were dominated by three themes in 2024: one, the rise of artificial intelligence (AI) and its derivatives; two, the strong performance of rate‑sensitive cyclical stocks in anticipation of Fed cuts; and three, soaring valuations of perceived “safe bets” despite unchanged earnings growth. In 2025, all three of these themes could unwind.
The growth rate of AI infrastructure is likely to slow due to increased competition. Cyclical stocks’ valuations are currently high after strong performance this year, although their risk/reward profile is more mixed for 2025. Many of the stocks are now at or near all‑time high valuations, with low expected growth rates.
Stretched valuations suggest that U.S. stocks will underperform bonds in the medium term (Figure 1). However, a combination of improving earnings and lower rates could result in a soft landing. We believe the Fed will continue to be data‑dependent when determining the speed and extent of the rate‑cutting cycle.
That said, we see a broadening opportunity set in U.S. equity markets, spanning several sectors. Small‑caps, which are trading at a historic discount to large‑caps, should benefit from further rate cuts and any signs of an improving economy. In addition, the current position of the energy cost curve indicates that we could be in for a multiyear regime change of capex and investment spend in energy, which would also benefit small‑cap stocks.
From a sector perspective, financials looks interesting. After Fed rate increases led to such poor performance for banks and real estate investment trusts in 2024, the market is anticipating better performance for this rate‑sensitive group should rate cuts continue into 2025. Energy has also underperformed significantly over the past year, but we see reasonable upside potential in several subsectors. Natural gas is attractive and likely to outperform due to limiting supply from rig count restrictions and pipeline constraints, and there is a longer‑term case for carbon‑based fuels owing to slower technological productivity gains and a delay in peak demand until after 2035.
We see company‑specific opportunities in industrials given the normalization of markets following the post‑COVID volatility. Most of these are in aerospace, electrical contractors, agriculture, municipal spending, and consumer‑related building products. In health care, the life sciences sector appears likely to benefit from a reacceleration of growth in biopharma production and as early‑stage research picks back up after some major patent expirations among large pharmaceutical firms.
Elsewhere, there are plenty of software firms that were not immediate beneficiaries of AI that have strong earnings growth prospects and are attractively valued. Although utilities have traded higher recently, the sector should benefit from rising demand due to AI, and is therefore likely to deliver faster earnings growth.
Overall, we anticipate a continued expansion of investible opportunities, characterized by historically attractive valuations in certain sectors, the normalization of fundamental trends post‑COVID, and improvement in growth aided by lower interest rates and fiscal support.
Key takeaway
The key trends that dominated U.S. equities in 2024 may fade in 2025, but this will likely expand the opportunity set.
Steph Jackson is the head of T. Rowe Price Investment Management. He is a member of the Management Committee and a member of the Black Leadership Council, and is the Executive Sponsor of Moonshot, a T. Rowe Price Foundation sponsored program supporting for-profit and non-profit entrepreneurs of color. He is the chair of the T. Rowe Price Investment Management (TRPIM) Investment Steering Committee, a member of the Investment Management Committee, TRPIM ESG and Product Strategy Committees. Steph also is the president of T. Rowe Price Investment Management, Inc.
Each month, our Investment Committee prepare a report revealing the two market themes they are watching, their bull and bear views per region and their latest asset class over and underweights.
It has been designed to aid you in your decision making and client conversations.
T. Rowe Price cautions that economic estimates and forward‑looking statements are subject to numerous assumptions, risks, and uncertainties, which change over time. Actual outcomes could differ materially from those anticipated in estimates and forward‑looking statements, and future results could differ materially from any historical performance. The information presented herein is shown for illustrative, informational purposes only. Any historical data used as a basis for this analysis are based on information gathered by T. Rowe Price and from third‑party sources and have not been independently verified.
Forward‑looking statements speak only as of the date they are made, and T. Rowe Price assumes no duty to and does not undertake to update forward‑looking statements.
Where securities are mentioned, the specific securities identified and described are for informational purposes only and do not represent recommendations.
Additional Disclosures
For more information on Third Party Market Data please visit troweprice.com/marketdata.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Important Information
This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.
Australia—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Clients only.
Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to Accredited Investors as defined under National Instrument 45‑106. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.
EEA—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L‑1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only.
New Zealand—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.
Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only.
UK—This material is issued and approved by T. Rowe Price International Ltd, Warwick Court, 5 Paternoster Square, London EC4M 7DX which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.
USA—Issued in the USA by T. Rowe Price Investment Management, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.
© 2024 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.